Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Cilostazol 100mg Tablet
Therapeutic Category
Neurology, Cardiology, Cardiovascular
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹329/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Cilospace 100 Tablet contains Cilostazol 100mg, a selective phosphodiesterase III inhibitor with antiplatelet and vasodilatory properties. It is primarily used to manage symptoms of intermittent claudication caused by peripheral arterial disease (PAD). Cilostazol works by inhibiting platelet aggregation and promoting vasodilation in the blood vessels, thereby enhancing blood flow, especially in the lower limbs. This improves oxygen delivery to muscles and helps patients walk longer distances without pain. Over time, it assists in reducing leg cramping and discomfort associated with walking due to poor circulation. The tablet is part of a therapeutic approach aimed at improving walking ability and quality of life in patients with chronic arterial insufficiency.
While generally well tolerated, Cilosize 100 Tablet may cause some side effects in certain individuals. The most commonly reported adverse effects include headache, palpitations, dizziness, and gastrointestinal disturbances such as diarrhea or abdominal discomfort. In rare cases, patients may experience chest pain, irregular heartbeat, or signs of bleeding. These side effects are typically mild and transient, but persistent or severe reactions should be promptly reported to a healthcare professional.
Cilospace 100 Tablet is indicated for the treatment of intermittent claudication, a condition characterized by pain or cramping in the legs during walking due to inadequate blood supply. It is used in patients with peripheral arterial disease to improve walking distance and reduce symptoms associated with impaired blood flow. The medicine is intended for individuals who do not respond adequately to lifestyle changes and exercise therapy alone. It may also be prescribed as supportive treatment in other vascular disorders, under medical supervision.
Cilospace 100 Tablet is contraindicated in patients with any degree of congestive heart failure due to an increased risk of cardiac complications. Caution is advised in individuals with a history of bleeding disorders, peptic ulcer disease, or those taking anticoagulant or antiplatelet medications. Liver or kidney impairment should be considered before initiating treatment. This medicine is not recommended during pregnancy or lactation unless specifically prescribed by a physician. Patients should undergo periodic monitoring to assess cardiovascular status and overall tolerance to therapy.
The tablet should be stored at a temperature not exceeding 25°C, in a cool and dry environment, protected from moisture and direct sunlight. It should be kept out of reach of children and not used beyond the expiry date printed on the packaging.
Composition : Olmesartan Medoxomil (20mg) + Cilnidipine (10mg) + Chlorthalidone (12.5mg) Tablet
Composition : Aceclofenac (200mg) + Pregabalin (75mg) Tablet
Composition : Methylcobalamin (1500mcg) + Alpha Lipoic Acid (100mg) + Vitamin B6 (Pyridoxine) (3mg) + Folic Acid (1.5mg) + Vitamin D3 (1000IU)
Composition : Calcium Carbonate (1250mg) + Vitamin D3 (2000IU) + Methylcobalamin (1500mcg) + L-Methyl Folate Calcium (1mg) + Pyridoxal-5-phosphate (0.5mg)
Composition : Sodium Valproate I.P. 133mg + Valproic Acid I.P. 58mg (C.R.)
Composition : Gabapentin (300mg) + Methylcobalamin (500mcg)
Composition : Sodium Valproate (333mg) + Valproic Acid (145mg) Tablet
Composition : Sodium Valproate 200mg + Valproic Acid 87mg
Composition : Divalproex (500mg) Prolonged Release Tablet
Composition : Divalproex (250mg) Prolonged Release
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Cilostazol 100 mg Tablet has strong demand in the antiplatelet and vascular care segment, making it a profitable product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from the consistent demand for Cilostazol 100 mg Tablet in peripheral vascular disease and blood circulation management. Including this product helps strengthen their cardiology and vascular care portfolio.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities for Cilostazol 100 mg Tablet with monopoly rights, promotional support, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from attractive business margins, timely product availability, professional marketing support, and access to a trusted vascular and antiplatelet pharmaceutical range when partnering with Cafoli Lifecare for this formulation.
Medical distributors, stockists, wholesalers, and pharma professionals interested in Cilostazol 100 mg Tablet can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk orders, pricing details, and distribution support services.